BR112017016895A2 - processo de produção de gonadotrofina - Google Patents
processo de produção de gonadotrofinaInfo
- Publication number
- BR112017016895A2 BR112017016895A2 BR112017016895A BR112017016895A BR112017016895A2 BR 112017016895 A2 BR112017016895 A2 BR 112017016895A2 BR 112017016895 A BR112017016895 A BR 112017016895A BR 112017016895 A BR112017016895 A BR 112017016895A BR 112017016895 A2 BR112017016895 A2 BR 112017016895A2
- Authority
- BR
- Brazil
- Prior art keywords
- production process
- gonadotropin production
- host cell
- gonadotropin
- hcg
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 102000006771 Gonadotropins Human genes 0.000 title 1
- 108010086677 Gonadotropins Proteins 0.000 title 1
- 239000002622 gonadotropin Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C12Y204/99004—Beta-galactoside alpha-2,3-sialyltransferase (2.4.99.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
a presente invenção refere-se a uma célula hospedeira caracterizada em que ela compreende integrada em seu genoma uma sequência codificando a cadeia alfa de hcg, e uso da célula hospedeira para produção de hcg recombinante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15164965 | 2015-04-24 | ||
PCT/EP2016/059006 WO2016170113A1 (en) | 2015-04-24 | 2016-04-22 | Method of production of gonadotrophin |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017016895A2 true BR112017016895A2 (pt) | 2018-03-27 |
Family
ID=53002568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017016895A BR112017016895A2 (pt) | 2015-04-24 | 2016-04-22 | processo de produção de gonadotrofina |
Country Status (32)
Country | Link |
---|---|
US (1) | US10464984B2 (pt) |
EP (1) | EP3286209B1 (pt) |
JP (1) | JP6964519B2 (pt) |
KR (1) | KR102658666B1 (pt) |
CN (2) | CN114107315A (pt) |
AU (1) | AU2016251314B2 (pt) |
BR (1) | BR112017016895A2 (pt) |
CA (1) | CA2975449A1 (pt) |
CL (1) | CL2017002661A1 (pt) |
CO (1) | CO2017011964A2 (pt) |
DK (1) | DK3286209T3 (pt) |
EA (1) | EA034022B1 (pt) |
ES (1) | ES2837111T3 (pt) |
HK (1) | HK1246325A1 (pt) |
HR (1) | HRP20201945T1 (pt) |
HU (1) | HUE051879T2 (pt) |
IL (1) | IL253694B (pt) |
LT (1) | LT3286209T (pt) |
MA (1) | MA41949B1 (pt) |
MD (1) | MD3286209T2 (pt) |
MX (1) | MX2017010884A (pt) |
MY (1) | MY185823A (pt) |
PH (1) | PH12017501585A1 (pt) |
PT (1) | PT3286209T (pt) |
RS (1) | RS61163B1 (pt) |
SA (1) | SA517390029B1 (pt) |
SG (1) | SG11201706832PA (pt) |
SI (1) | SI3286209T1 (pt) |
TN (1) | TN2017000328A1 (pt) |
UA (1) | UA124187C2 (pt) |
WO (1) | WO2016170113A1 (pt) |
ZA (1) | ZA201707136B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112020003379A2 (pt) | 2017-09-01 | 2020-08-25 | Ferring B.V. | usos de hormônio folículo-estimulante recombinante (fsh) para estimulação ovariana controlada |
CN108264549A (zh) * | 2018-03-29 | 2018-07-10 | 北京伟杰信生物科技有限公司 | 重组绒促性素rhCG的制备方法及应用 |
TW201945024A (zh) | 2018-04-30 | 2019-12-01 | 荷蘭商菲林公司 | 用於經控制之卵巢刺激的組成物 |
CN110812366B (zh) * | 2019-11-18 | 2023-11-17 | 珠海丽凡达生物技术有限公司 | 一种可用于激素补充的mRNA药物及其制备方法 |
CN113337562B (zh) * | 2021-05-24 | 2022-06-03 | 宁波人健药业集团股份有限公司 | 使用CHO细胞高效发酵生产rhCG的方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6855544B1 (en) | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
WO2001058493A1 (en) * | 2000-02-11 | 2001-08-16 | Maxygen Aps | Conjugates of follicle stimulating hormones |
US20030036181A1 (en) | 2000-06-30 | 2003-02-20 | Okkels Jens Sigurd | Peptide extended glycosylated polypeptides |
CN1194016C (zh) * | 2000-12-29 | 2005-03-23 | 申庆祥 | 新的人绒毛膜***-促黄体素融合蛋白及其制法和用途 |
CN101250531B (zh) * | 2006-11-27 | 2013-04-24 | 株式会社Lg生命科学 | 一核苷酸序列、包含该序列的表达载体、该载体转化的动物细胞及利用该细胞生产人fsh的方法 |
TWI604850B (zh) | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
US8326547B2 (en) * | 2009-10-07 | 2012-12-04 | Nanjingjinsirui Science & Technology Biology Corp. | Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm |
CA2784861A1 (en) * | 2009-12-21 | 2011-07-14 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
JP2015518705A (ja) * | 2012-04-02 | 2015-07-06 | モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. | ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド |
DE18200782T1 (de) | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen |
CN103539862B (zh) * | 2013-11-01 | 2015-04-01 | 广州联康生物科技有限公司 | 一种长效重组促卵泡激素及其应用 |
-
2016
- 2016-04-22 WO PCT/EP2016/059006 patent/WO2016170113A1/en active Application Filing
- 2016-04-22 KR KR1020177022423A patent/KR102658666B1/ko active IP Right Grant
- 2016-04-22 MX MX2017010884A patent/MX2017010884A/es unknown
- 2016-04-22 ES ES16721722T patent/ES2837111T3/es active Active
- 2016-04-22 MD MDE20180206T patent/MD3286209T2/ro unknown
- 2016-04-22 MY MYPI2017703981A patent/MY185823A/en unknown
- 2016-04-22 EA EA201791724A patent/EA034022B1/ru unknown
- 2016-04-22 PT PT167217223T patent/PT3286209T/pt unknown
- 2016-04-22 MA MA41949A patent/MA41949B1/fr unknown
- 2016-04-22 DK DK16721722.3T patent/DK3286209T3/da active
- 2016-04-22 BR BR112017016895A patent/BR112017016895A2/pt active Search and Examination
- 2016-04-22 UA UAA201711487A patent/UA124187C2/uk unknown
- 2016-04-22 US US15/566,961 patent/US10464984B2/en active Active
- 2016-04-22 JP JP2017555503A patent/JP6964519B2/ja active Active
- 2016-04-22 RS RS20201492A patent/RS61163B1/sr unknown
- 2016-04-22 AU AU2016251314A patent/AU2016251314B2/en active Active
- 2016-04-22 TN TNP/2017/000328A patent/TN2017000328A1/en unknown
- 2016-04-22 LT LTEP16721722.3T patent/LT3286209T/lt unknown
- 2016-04-22 CN CN202111399800.1A patent/CN114107315A/zh active Pending
- 2016-04-22 HU HUE16721722A patent/HUE051879T2/hu unknown
- 2016-04-22 EP EP16721722.3A patent/EP3286209B1/en active Active
- 2016-04-22 CA CA2975449A patent/CA2975449A1/en active Pending
- 2016-04-22 SI SI201631009T patent/SI3286209T1/sl unknown
- 2016-04-22 CN CN201680022637.8A patent/CN107532172A/zh active Pending
- 2016-04-22 SG SG11201706832PA patent/SG11201706832PA/en unknown
-
2017
- 2017-07-27 IL IL253694A patent/IL253694B/en unknown
- 2017-09-04 PH PH12017501585A patent/PH12017501585A1/en unknown
- 2017-09-26 SA SA517390029A patent/SA517390029B1/ar unknown
- 2017-10-19 CL CL2017002661A patent/CL2017002661A1/es unknown
- 2017-10-20 ZA ZA2017/07136A patent/ZA201707136B/en unknown
- 2017-11-24 CO CONC2017/0011964A patent/CO2017011964A2/es unknown
-
2018
- 2018-05-08 HK HK18105909.9A patent/HK1246325A1/zh unknown
-
2020
- 2020-12-04 HR HRP20201945TT patent/HRP20201945T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017016895A2 (pt) | processo de produção de gonadotrofina | |
AR118777A2 (es) | Neurotoxinas catiónicas | |
BR112018007017A2 (pt) | polipeptídeos | |
BR112019000718A2 (pt) | processo para a produção de geopolímero ou compósito de geopolímero | |
CR20150466A (es) | Péptidos y composiciones para el tratamiento de daño articular | |
BR112017011217A2 (pt) | impurezas de dna em uma composição compreendendo um vírion parvoviral | |
BR112018011787A2 (pt) | processo de envase a quente com fechos feitos de composições de polietileno bimodal | |
CL2013002044A1 (es) | Anticuerpo que une il-17a humano e il-17f humano; secuencia de adn que lo codifica; vector; celula huesped; proceso de produccion; composicion farmaceutica que lo comprende; y su uso para el tratamiento profilaxis de un trastorno patologico mediado por il-17a y/o il-17f. | |
BR112017013394A2 (pt) | fabricação de proteína | |
CL2014000291A1 (es) | Vacuna que comprende al menos 30 aminoacidos de un polipeptido de p62/sqstm1 o un acido nucleico que lo codifica; y su uso para el tratamiento y profilaxis del cancer. | |
BR112018012444A2 (pt) | processo para a produção de ácido orto-aminobenzoico e/ou anilina com o uso de levedura recombinante | |
BR112017000293A2 (pt) | processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina | |
BR112015018599A2 (pt) | Micro-organismos com produtividade de putrescina e processo para produzir putrescina que utiliza os mesmos | |
AR079821A1 (es) | Cepas y metodo para la produccion de metionina | |
BR112018010387A8 (pt) | levedura geneticamente modificada e processo para fabricar etanol | |
BR112017004233A2 (pt) | polipeptídeos tendo atividade de xilanase com uma alta taxa de conversão de polissacarídeos contendo xilose | |
BR112017005109A2 (pt) | produto refratário com base em al2o3, composição de matérias-primas para a fabricação do produto, método para a fabricação de um produto refratário, produto refratário, e emprego do produto refratário | |
BR112018013180A2 (pt) | partículas zeolíticas com dimensões nanométricas e processo para produção das mesmas | |
BR112017028065A2 (pt) | sistema de bioacabamento | |
CO2019003429A2 (es) | Salsa de tomate con estabilidad de almacenamiento mejorada | |
BR112018003778A2 (pt) | animal transgênico para produção de anticorpos que apresenta uma cadeia leve comum | |
CL2017001383A1 (es) | Proceso para la fabricación de anhídrido carboxílico | |
BR112016017281A2 (pt) | microrganismos produtores de l-aminoácidos e processo para produção de l-aminoácidos usando os mesmos | |
BR112018069435A2 (pt) | composição de polímero de etileno, artigo, e, processo para produzir um artigo. | |
BR112018008045A2 (pt) | micro-organismo recombinante que produz l-treonina e um método para produzir l-treonina com o uso do mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] |